[1] In late 2001 EnCor rented lab space at the Sid Martin Biotechnology Incubator, a facility dedicated to commercialization of intellectual property generated in the University of Florida.
Following this move the EnCor laboratory produced an increasing number of novel antibodies which were made, characterized, documented, manufactured and subjected to rigorous quality control.
[2] EnCor has always collaborated with basic scientists and clinicians to produce articles in peer-reviewed scientific publications focused on the examination of various plasma, serum and CSF biomarkers of nervous system damage and degeneration.
In 2022 EnCor, in collaboration with researchers at the University of Florida described a novel class of antibodies to neurofilament light chain with the HGNC name NEFL, although the protein is usually referred to as NF-L.
EnCor is well known for the quality of its cell, tissue and western blotting images, many of which have been made available on Wikipedia Commons and widely used in books, articles, posters, for teaching, advertising and many other purposes, see [1].